This Article Full Text Full Text (PDF) All Versions of this Article: 110/3/309    most recent 01.CIR.0000135475.35758.23v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hu, C.-M. Articles by Chau, L.-Y. Search for Related Content PubMed PubMed Citation Articles by Hu, C.-M. Articles by Chau, L.-Y. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Remodeling Hypertrophy Oxidant stress

(Circulation. 2004;110:309-316.)
© 2004 American Heart Association, Inc.

Original Articles

Heme Oxygenase-1 Inhibits Angiotensin II-Induced Cardiac Hypertrophy In Vitro and In Vivo

Chien-Ming Hu, PhD; Yen-Hui Chen, DVM, VMDr; Ming-Tsai Chiang, MS; Lee-Young Chau, PhD

From the Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China.

Correspondence to Lee-Young Chau, PhD, Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan, Republic of China. E-mail lyc{at}ibms.sinica.edu.tw

Received September 1, 2003; de novo received January 27, 2004; revision received April 1, 2004; accepted April 4, 2004.

Background— Heme oxygenase-1 (HO-1) is a stress-response enzyme implicated in cardioprotection. To explore whether HO-1 has a role in cardiac remodeling response, the effect of its overexpression on angiotensin II (Ang II)-induced cardiac hypertrophy was examined.

Methods and Results— HO-1 was induced in cultured rat neonatal cardiomyocytes by treatment with cobalt protoporphyrin IX (CoPPIX) or a recombinant adenovirus carrying the human HO-1 gene. Ang II-induced myocyte hypertrophy assessed by increments in cell size, [³H]leucine uptake, and protein content was suppressed by HO-1 overexpression. Cotreatment of cells with tin protoporphyrin IX, a HO inhibitor, significantly reversed the suppressive effect of HO-1. Bilirubin, one of the byproducts of heme degradation by HO-1, mediated the suppressive effect through the inhibition of Ang II-induced production of reactive oxygen species, as detected by a 2',7'-dichlorofluorescein probe. The antihypertrophic effect of HO-1 was also demonstrated in rats receiving chronic Ang II infusions. Cotreatment of animals with CoPPIX significantly attenuated Ang II-induced left ventricular hypertrophy and hyperdynamic contractions, whereas concomitant treatment with tin protoporphyrin IX abolished CoPPIX-mediated cardioprotection in vivo.

Conclusions— HO-1 attenuates Ang II-induced cardiac hypertrophy both in vitro and in vivo, and bilirubin mediates, at least in part, the antihypertrophic effect of HO-1 via inhibition of reactive oxygen species production after Ang II stimulation.

Key Words: heme oxygenase • angiotensin • hypertrophy

This article has been cited by other articles:

				J. Li, T. Ichikawa, L. Villacorta, J. S. Janicki, G. L. Brower, M. Yamamoto, and T. Cui Nrf2 Protects Against Maladaptive Cardiac Responses to Hemodynamic Stress Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1843 - 1850. [Abstract] [Full Text] [PDF]

				A. Jadhav and J. F. Ndisang Heme Arginate Suppresses Cardiac Lesions and Hypertrophy in Deoxycorticosterone Acetate-Salt Hypertension Experimental Biology and Medicine, July 1, 2009; 234(7): 764 - 778. [Abstract] [Full Text] [PDF]

				K. R. Brunt, M. R. Tsuji, J. H. Lai, R. T. Kinobe, W. Durante, W. C. Claycomb, C. A. Ward, and L. G. Melo Heme Oxygenase-1 Inhibits Pro-Oxidant Induced Hypertrophy in HL-1 Cardiomyocytes Experimental Biology and Medicine, May 1, 2009; 234(5): 582 - 594. [Abstract] [Full Text] [PDF]

				S. Mito, R. Ozono, T. Oshima, Y. Yano, Y. Watari, Y. Yamamoto, A. Brydun, K. Igarashi, and M. Yoshizumi Myocardial Protection Against Pressure Overload in Mice Lacking Bach1, a Transcriptional Repressor of Heme Oxygenase-1 Hypertension, June 1, 2008; 51(6): 1570 - 1577. [Abstract] [Full Text] [PDF]

				J. Tongers, J.-M. Knapp, M. Korf, T. Kempf, A. Limbourg, F. P. Limbourg, Z. Li, D. Fraccarollo, J. Bauersachs, X. Han, et al. Haeme oxygenase promotes progenitor cell mobilization, neovascularization, and functional recovery after critical hindlimb ischaemia in mice Cardiovasc Res, May 1, 2008; 78(2): 294 - 300. [Abstract] [Full Text] [PDF]

				D. Frank, C. Kuhn, B. Brors, C. Hanselmann, M. Ludde, H. A. Katus, and N. Frey Gene Expression Pattern in Biomechanically Stretched Cardiomyocytes: Evidence for a Stretch-Specific Gene Program Hypertension, February 1, 2008; 51(2): 309 - 318. [Abstract] [Full Text] [PDF]

				Y. Cheng, R. Ji, J. Yue, J. Yang, X. Liu, H. Chen, D. B. Dean, and C. Zhang MicroRNAs Are Aberrantly Expressed in Hypertrophic Heart: Do They Play a Role in Cardiac Hypertrophy? Am. J. Pathol., June 1, 2007; 170(6): 1831 - 1840. [Abstract] [Full Text] [PDF]

				A. Sabri and P. A. Lucchesi ANG II and cardiac myocyte contractility: p38 is not stressed out! Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H72 - H73. [Full Text] [PDF]

				G. L. Volti, C.-M. Hu, Y.-H. Chen, M.-T. Chiang, and L.-Y. Chau Letter Regarding Article by Hu et al, "Heme Oxygenase-1 Inhibits Angiotensin II-Induced Cardiac Hypertrophy In Vitro and In Vivo" * Response Circulation, February 15, 2005; 111(6): e100 - e100. [Full Text] [PDF]